Australia could be on the cusp of a major breakthrough in the fight against Alzheimer’s disease, with researchers advancing a blood test capable of identifying people at elevated risk decades before symptoms emerge. The development comes with dementia now identified as the leading cause of death in Australia and affects an estimated 447,000 Australians.
The Federal Government has backed the launch of a new Centre of Excellence in Sydney aimed at addressing critical gaps in Alzheimer’s research across Australia and the Asia-Pacific region. Speaking on ABC Sydney Drive, Health, Disability and Ageing Minister Mark Butler described the emerging blood test as a potentially significant step forward in improving early detection and diagnosis.
The proposed test works by identifying biomarkers associated with Alzheimer’s disease, including the APOE4 gene and specific proteins such as tau. What sets the technology apart is its potential to identify risk years, or even decades, before any symptoms become apparent. Researchers believe this could give individuals valuable time to make lifestyle changes and seek medical advice earlier than is currently possible.
While the Minister stressed that the test is not a definitive predictor of Alzheimer’s and should not be viewed as a “silver bullet,” it could significantly improve Australia’s ability to diagnose and monitor the disease.
The prospect of learning about a heightened Alzheimer’s risk decades in advance raises important questions for many Australians. Some may wonder whether knowing early would be beneficial given that there is currently no cure for the disease. However, health experts increasingly point to a range of modifiable risk factors linked to dementia, including smoking, poor diet, lack of physical activity and other lifestyle factors. Would early awareness encourage people to adopt healthier habits that may reduce their overall risk and improve long-term brain health?
Pathway to Medicare funding still ahead
Although the blood test is generating excitement, Australians should not expect immediate Medicare coverage.
Before the test can be covered by Medicare, researchers at the University of New South Wales, working in partnership with Roche Diagnostics, must first demonstrate its effectiveness through Australian clinical data. If the evidence confirms the test can accurately identify people at risk of Alzheimer’s disease, it will be submitted to the independent experts who assess new services for inclusion on the Medicare Benefits Schedule (MBS). Should the test receive approval, eligible patients would be able to access it with Medicare support, helping make the potentially groundbreaking screening tool more widely available
Until then, some forms of testing may be available privately, particularly for people with family histories or other risk factors associated with Alzheimer’s disease. Australians interested in accessing the test before any Medicare decision is made are encouraged to contact NeuRA, the neuroscience research institute based at the University of New South Wales’ Randwick campus, which is involved in the project.
New Treatments Offer Hope
The push for earlier diagnosis comes as new Alzheimer’s treatments begin emerging internationally. Researchers and pharmaceutical companies continue investing heavily in the search for more effective therapies. Yet experts acknowledge that major challenges remain, including improving diagnosis, expanding support services and ultimately finding treatments that can substantially alter the course of the disease.
The development of a reliable Alzheimer’s blood test represents one of the most promising advances in dementia care in recent years. While further clinical validation and regulatory assessment are required before widespread adoption, the technology could eventually transform how Australia identifies and manages one of its most challenging health conditions.
For more detailed information, including discussion of Medicare eligibility, treatment developments and NDIS-related issues, the full interview transcript with Minister Mark Butler on ABC Sydney Drive is available by clicking on the following link: Radio interview with Minister Butler, ABC Sydney Drive – 30 July 2026 or listen to the interview by clicking here (min 1:03:50)
Other Links and Resources:
Neura News Article Article
Dementia support Australia (DSA)
DSA Support for Health Care Professionals